Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. May 15, 2017; 9(5): 218-227
Published online May 15, 2017. doi: 10.4251/wjgo.v9.i5.218
Published online May 15, 2017. doi: 10.4251/wjgo.v9.i5.218
Table 2 Pre-operative and operative treatment details
| Incidence of neoadjuvant chemoradiation | |
| Primary cancer | |
| Colorectal | 75% |
| Chordoma | 0% |
| Gynaecological | 0% |
| Recurrent cancer | |
| Colorectal | 67% |
| Gynaecological | 0% |
| Operative procedure, n (%) | |
| Total PE | 1 (4) |
| Total PE with lateral exenteration | 9 (36) |
| Anterior PE | 3 (12) |
| Anterior and Lateral PE | 1 (4) |
| Posterior PE | 2 (8) |
| Posterior and Lateral PE | 5 (20) |
| Lateral PE | 4 (16) |
| Sacrectomy combined with any above PE procedures | 9 (36) |
- Citation: Chew MH, Yeh YT, Toh EL, Sumarli SA, Chew GK, Lee LS, Tan MH, Hennedige TP, Ng SY, Lee SK, Chong TT, Abdullah HR, Goh TLH, Rasheed MZ, Tan KC, Tang CL. Critical evaluation of contemporary management in a new Pelvic Exenteration Unit: The first 25 consecutive cases. World J Gastrointest Oncol 2017; 9(5): 218-227
- URL: https://www.wjgnet.com/1948-5204/full/v9/i5/218.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i5.218